Cold Chain Service Providers to Benefit From the Strong growth of the Biopharmaceutical Market

Top Quote A new report from IMARC Group expects the strong growth of biopharmaceuticals and the launch of biosimilars to create huge opportunities for cold chain service providers. End Quote
  • (1888PressRelease) September 02, 2011 - Driven by strong efficacies, target oriented attack and high margins; the market for biopharmaceuticals is expected to grow robustly in the coming years reaching values worth US$ 159 Billion by 2016. IMARC Group, one of the worlds's leading research and advisory firms in its new report "Global Healthcare Cold Chain Logistics Market Report & Forecast (2011-2016)" expects the growth of the biopharmaceutical market to create huge demand for efficient cold chain logistic services. Findings from the report suggest that biopharmaceuticals are highly temperature sensitive and are recommended to be stored and transported at temperatures ranging from 2°- 8°C. Any failures in the cold chain transportation of these drugs can lead to a significant loss of their efficacy and can even make them harmful for the patient. Regulatory agencies have in fact stated that drugs that have been temperature abused are every bit as dangerous as those that are not authentic.

    Findings from the report also suggest that the entry of biosimilars or generic versions of branded biopharmaceuticals will further increase the demand for cold chain logistic services. The reports expect biosimilars to be 20% - 60% cheaper than branded biopharmaceuticals. This is expected to significantly increase their patient pools and thereby expand the overall shipment volume of these drugs. The report also expects some of the important biosimilar manufactures to be based in Asian Countries e.g. Dr Reddy's (India), Celltrion (Korea), etc. Since the manufacturing facilities of these companies will be based in Asia and their end user markets will be based in the US and Europe, the report expects a significant increase in the exports of biopharmaceuticals between these regions.

    Key Aspects Analyzed in this Report:
    Comprehensive Market Analysis of Temperature Sensitive Health Care Products:
    Classes Covered: Biopharmaceuticals, Vaccines & Clinical Trial Materials

    Focus of the Analysis in Each Class:
    • Drivers and challenges
    • Historical sales trends
    • Logistic requirements
    • Impact of temperature excursions
    • Opportunities in cold chain services
    • Market outlook (2011-2016)

    Understanding the Operations of a Health Care Cold Chain Distribution Process
    Focus of the Analysis:
    • Understanding the various methods of cold chain distribution and their advantages/disadvantages
    • Understanding the cold chain requirements of various temperature sensitive products and the impact of temperature excursion
    • Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation
    • Understanding the key steps required in the setting and organization of an efficient cold chain distribution process

    Comprehensive Market Analysis of the Health Care Cold Chain Logistic Services Market
    Focus of the analysis:
    • Quantifying the global health care cold chain logistic services market
    • Quantifying the market size by product
    • Quantifying the market size by service
    • Quantifying the market size by region

    Information Sources:
    Information has been sourced from both primary and secondary sources:
    • Primary sources include industry surveys and face to face/telephone interviews with industry experts.
    • Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.

    Table of Contents:

    1 Research Methodology & Market Definitions
    2 Executive Summary
    3 The Global Healthcare Cold Chain Logistics Market
    3.1 Current Trends
    3.1.1 Healthcare Cold Chain Products are Exhibiting Exponential Growth
    3.1.2 Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
    3.1.3 Outsourcing Trends in Research & Manufacturing Have Increased Logistic Demands
    3.1.4 Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
    3.1.5 Cost is Not Always the Most Important Driver in Supplier Decisions
    4 The Global Healthcare Cold Chain Products Market
    4.1 Current Market Trends & Forecast
    4.2 Market Segments
    4.2.1 Biopharmaceuticals
    4.2.1.1 Current Market Trends & Forecast
    4.2.1.2 Cold Chain Requirements for Biopharmaceuticals
    4.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
    4.2.2 Vaccines
    4.2.2.1 Current Market Trends & Forecast
    4.2.2.2 Cold Chain Requirements for Vaccines
    4.2.2.3 Cold Chain Opportunities for Vaccines
    4.2.3 Clinical Trial Materials
    4.2.3.1 Current Market Trends & Forecast
    4.2.3.2 Cold Chain Requirements for Clinical Trial Materials
    4.2.3.3 Cold Chain Opportunities for Clinical Trial Materials
    5 Healthcare Cold Chain Logistics: How Does It Operate?
    5.1 Cold Chain Packaging & Transportation Methods
    5.1.1 Dry Ice
    5.1.2 Liquid Nitrogen
    5.1.3 Gel Packs
    5.2 Modeling the Cost of Cold Chain Packaging & Transportation
    5.3 The Setting & Organization of Cold Chains
    5.3.1 Initial Considerations
    5.3.2 Choosing the Correct Model
    5.3.3 Regulatory/Custom Clearance
    5.3.4 Final Stages
    5.3.5 Quality Assurance
    6 The Healthcare Cold Chain Logistic Services Market
    6.1 Current Trends & Forecast
    6.2 Market Segmentation
    6.2.1 Market by Product
    6.2.1.1 Biopharmaceuticals & Vaccines
    6.2.1.2 Clinical Trial Materials
    6.2.2 Market by Service
    6.2.2.1 Packaging & Instrumentation
    6.2.2.2 Transportation
    6.2.3 Market by Region
    6.2.3.1 North America
    6.2.3.2 Europe
    6.2.3.3 Asia Pacific
    6.2.3.4 Rest of the World
    7 Challenges in the Healthcare Cold Chain Logistics Market
    7.1 Cold Chain Infrastructure Remains Underdeveloped in Many Regions
    7.2 Lack of Funding to Implement an Efficient Cold Chain Infrastructure
    7.3 New Technologies Nullifying the Need of Cold Chains
    8 Key Company Profiles
    8.1 World Courier
    8.2 DHL
    8.3 Fedex
    8.4 United Parcel Service
    8.5 Kuehne and Nagel
    8.6 Cavalier Logistics
    8.7 DB Schenker
    8.8 Life ConEx
    8.9 American Airlines Cargo
    8.10 Continental Air Cargo
    8.11 Marken

    To buy the complete report or to get a free sample:
    Call: +91-120-425-6531 (Asia), +1-631-791-1145 (America)
    email: sales ( @ ) imarcgroup dot com
    For more information please visit: www.imarcgroup.com

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information
  • Krishna Sharma
  • Imarc Group
  • 21/601 Eastend Apartment Mayur Vihar Phase-1 Extention Delhi-110096, India
  • 110096
  • Voice: 91-11-43095788
  • Visit our Site